-
1por Modestino, Edward Justin, Blum, Kenneth, Dennen, Catherine A., Downs, B. William, Bagchi, Debasis, Llanos-Gomez, Luis, Elman, Igor, Baron, David, Thanos, Panayotis K., Badgaiyan, Rajendra D., Braverman, Eric R., Gupta, Ashim, Gold, Mark S., Bowirrat, AbdallaEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2por Blum, Kenneth, Han, David, Gupta, Ashim, Baron, David, Braverman, Eric R., Dennen, Catherine A., Kazmi, Shan, Llanos-Gomez, Luis, Badgaiyan, Rajendra D., Elman, Igor, Thanos, Panayotis K., Downs, Bill W., Bagchi, Debasis, Gondre-Lewis, Marjorie C., Gold, Mark S., Bowirrat, Abdalla“…While most of the research related to GARS is derived from our laboratory, we are encouraging more independent research to confirm our findings.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3por Gupta, Ashim, Bowirrat, Abdalla, Gomez, Luis Llanos, Baron, David, Elman, Igor, Giordano, John, Jalali, Rehan, Badgaiyan, Rajendra D., Modestino, Edward J., Gold, Mark S., Braverman, Eric R., Bajaj, Anish, Blum, Kenneth“…The GARS test results identify high-risk for both drug and alcohol, and H-Wave can be initiated to treat pain instead of opioids. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4por Blum, Kenneth, Brodie, Mark S., Pandey, Subhash C., Cadet, Jean Lud, Gupta, Ashim, Elman, Igor, Thanos, Panayotis K., Gondre-Lewis, Marjorie C., Baron, David, Kazmi, Shan, Bowirrat, Abdalla, Febo, Marcelo, Badgaiyan, Rajendra D., Braverman, Eric R., Dennen, Catherine A., Gold, Mark S.“…We present a hypothesis that identification of KCNK13 and RASGRF2 genes’ risk polymorphism, coupled with genetic addiction risk score (GARS)-guided precision pro-dopamine regulation, will mitigate binge alcohol drinking. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5por Ceccanti, Mauro, Blum, Kenneth, Bowirrat, Abdalla, Dennen, Catherine A., Braverman, Eric R., Baron, David, Mclaughlin, Thomas, Giordano, John, Gupta, Ashim, Downs, Bernard W., Bagchi, Debasis, Barh, Debmalya, Elman, Igor, Thanos, Panayotis K., Badgaiyan, Rajendra D., Edwards, Drew, Gold, Mark S.“…Therefore, based on this extensive literature and additional research, this team of coauthors suggests that, in the future, in addition to the current nonpharmacological therapies, patients with opioid-induced NAS should undergo genetic assessment (i.e., the genetic addiction risk severity (GARS) test), which can subsequently be used to guide DNA-directed precision amino-acid enkephalinase inhibition (KB220) therapy as a frontline modality instead of potent opioids.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6por Dennen, Catherine A., Blum, Kenneth, Bowirrat, Abdalla, Thanos, Panayotis K., Elman, Igor, Ceccanti, Mauro, Badgaiyan, Rajendra D., McLaughlin, Thomas, Gupta, Ashim, Bajaj, Anish, Baron, David, Downs, B. William, Bagchi, Debasis, Gold, Mark S.“…This case series presents the novel genetic addiction risk score (GARS), which shows a high prevalence of polymorphic risk alleles of reward genes in a nuclear family with multiple reward deficiency syndrome (RDS) behavioral issues expressing a hypodopaminergic antecedent. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
7por Blum, Kenneth, Han, David, Bowirrat, Abdalla, Downs, Bernard William, Bagchi, Debasis, Thanos, Panayotis K., Baron, David, Braverman, Eric R., Dennen, Catherine A., Gupta, Ashim, Elman, Igor, Badgaiyan, Rajendra D., Llanos-Gomez, Luis, Khalsa, Jag, Barh, Debmalya, McLaughlin, Thomas, Gold, Mark S.“…To develop an accurate test to help identify those at risk for at least alcohol use disorder (AUD), a subset of reward deficiency syndrome (RDS), Blum’s group developed the genetic addiction risk severity (GARS) test, consisting of ten genes and eleven associated risk alleles. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8por Dennen A., Catherine, Blum, Kenneth, Braverman R., Eric, Bowirrat, Abdalla, Gold, Marks, Elman, Igor, Thanos K., Panayotis, Baron, David, Gupta, Ashim, Edwards, Drew, Badgaiyan D., Rajendra“…Screening for preaddiction could be achieved through genetic testing (i.e., the genetic addiction risk severity (GARS) test) and/or through other neuropsychiatric testing (i.e., Memory (CNSVS), Attention (TOVA), Neuropsychiatric (MCMI-III), Neurological Imaging (qEEG/P300/EP)). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9por Blum, Kenneth, Bowirrat, Abdalla, Braverman, Eric R, Dennen, Catherine, Zeine, Foojan, Jafari, Nicole, Sunder, Keerthy, Thanos, Panayotis K., Baron, David, Barh, Debmayla, Gupta, Ashim, Bagchi, Debasis, Gold, Mark S, Badgaiyan, Rajendra D.“…The development of the Genetic Addiction Risk Severity (GARS) test, Blum’s group believes that this type of testing should be the “standard of care” following additional studies. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10por Blum, Kenneth, Dennen, Catherine A., Elman, Igor, Bowirrat, Abdalla, Thanos, Panayotis K., Badgaiyan, Rajendra D., Downs, B. William, Bagchi, Debasis, Baron, David, Braverman, Eric R., Gupta, Ashim, Green, Richard, McLaughlin, Thomas, Barh, Debmalya, Gold, Mark S.“…Epigenetic repair of hypodopaminergia, the causative basis of addictive behaviors, may involve precision DNA-guided therapy achieved by combining the Genetic Addiction Risk Severity (GARS) test with a researched neutraceutical having a number of variant names, including KB220Z. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto